New tyrosine kinase inhibitors in chronic myeloid leukemia (CML)

H. Kantarjian; J. Cortes

doi:10.1016/S0145-2126(07)70273-4

New tyrosine kinase inhibitors in chronic myeloid leukemia (CML)

H. Kantarjian, J. Cortes

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	S16-S19
Journal	Leukemia Research
Volume	31
Issue number	SUPPL. 2
DOIs	https://doi.org/10.1016/S0145-2126(07)70273-4
State	Published - Sep 2007
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0145-2126(07)70273-4

Cite this

@article{b8cbf61e15bb403a9413e51a8b687832,

title = "New tyrosine kinase inhibitors in chronic myeloid leukemia (CML)",

author = "H. Kantarjian and J. Cortes",

year = "2007",

month = sep,

doi = "10.1016/S0145-2126(07)70273-4",

language = "English (US)",

volume = "31",

pages = "S16--S19",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

number = "SUPPL. 2",

}

TY - JOUR

T1 - New tyrosine kinase inhibitors in chronic myeloid leukemia (CML)

AU - Kantarjian, H.

AU - Cortes, J.

PY - 2007/9

Y1 - 2007/9

UR - http://www.scopus.com/inward/record.url?scp=36049049350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36049049350&partnerID=8YFLogxK

U2 - 10.1016/S0145-2126(07)70273-4

DO - 10.1016/S0145-2126(07)70273-4

M3 - Article

AN - SCOPUS:36049049350

SN - 0145-2126

VL - 31

SP - S16-S19

JO - Leukemia Research

JF - Leukemia Research

IS - SUPPL. 2

ER -

New tyrosine kinase inhibitors in chronic myeloid leukemia (CML)

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this